These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33282074)

  • 21. Antimicrobial resistance: A challenge awaiting the post-COVID-19 era.
    Lobie TA; Roba AA; Booth JA; Kristiansen KI; Aseffa A; Skarstad K; Bjørås M
    Int J Infect Dis; 2021 Oct; 111():322-325. PubMed ID: 34508864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and antimicrobial resistance: A cross-study.
    Rizvi SG; Ahammad SZ
    Sci Total Environ; 2022 Feb; 807(Pt 2):150873. PubMed ID: 34634340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance.
    Kalam A; Shano S; Khan MA; Islam A; Warren N; Hassan MM; Davis M
    PLoS One; 2021; 16(12):e0261368. PubMed ID: 34905563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Antimicrobial resistance and stewardship in the COVID-19 era.
    Kakkar AK; Shafiq N
    Front Public Health; 2024; 12():1398981. PubMed ID: 38751594
    [No Abstract]   [Full Text] [Related]  

  • 25. The Pandemic beyond the Pandemic: A Scoping Review on the Social Relationships between COVID-19 and Antimicrobial Resistance.
    Toro-Alzate L; Hofstraat K; de Vries DH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-meta-analysis of co-infection, secondary infections, and antimicrobial resistance in COVID-19 patients.
    Suleiman AS; Islam MA; Akter MS; Amin MR; Werkneh AA; Bhattacharya P
    J Infect Public Health; 2023 Oct; 16(10):1562-1590. PubMed ID: 37572572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments.
    Pruden A; Vikesland PJ; Davis BC; de Roda Husman AM
    Curr Opin Microbiol; 2021 Dec; 64():91-99. PubMed ID: 34655936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective.
    Seethalakshmi PS; Charity OJ; Giakoumis T; Kiran GS; Sriskandan S; Voulvoulis N; Selvin J
    Sci Total Environ; 2022 Apr; 818():151702. PubMed ID: 34798093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
    Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P
    Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance.
    Seabra G; Ventura Mendes RF; Dos Santos Amorim LFV; Peregrino IV; Branquinha MH; Dos Santos ALS; Nunes APF
    Curr Top Med Chem; 2021; 21(8):677-683. PubMed ID: 34028347
    [No Abstract]   [Full Text] [Related]  

  • 32. A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future.
    Ohashi T; Nagashima M; Kawai N; Ohmagari N; Tateda K
    Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1603-1614. PubMed ID: 36368311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Systematic Review of Antimicrobial Resistance During the COVID-19 Pandemic.
    Burnside JSW; Buchthal OV; Patil U
    Hawaii J Health Soc Welf; 2023 Aug; 82(8):188-193. PubMed ID: 37559691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Starved of ACTION: A Critical Look at the Antimicrobial Resistance Action Plans of African Countries.
    Ohemu GP
    ACS Infect Dis; 2022 Aug; 8(8):1377-1380. PubMed ID: 35916786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?
    Pelfrene E; Botgros R; Cavaleri M
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):21. PubMed ID: 33514424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance and one health in the post COVID-19 era: What should health students learn?
    Elmahi OKO; Uakkas S; Olalekan BY; Damilola IA; Adedeji OJ; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY; Thomson DJ
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):58. PubMed ID: 35410463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic.
    Paula HSC; Santiago SB; Araújo LA; Pedroso CF; Marinho TA; Gonçalves IAJ; Santos TAP; Pinheiro RS; Oliveira GA; Batista KA
    Braz J Med Biol Res; 2021; 55():e11631. PubMed ID: 34909910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance: the good, the bad, and the ugly.
    Hardie KR
    Emerg Top Life Sci; 2020 Sep; 4(2):129-136. PubMed ID: 32463087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
    Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D
    Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.